Hotchkis & Wiley Capital Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,800
Closed -$481K 500
2022
Q3
$481K Buy
1,800
+200
+13% +$42.5K ﹤0.01% 508
2022
Q2
$326K Hold
1,600
﹤0.01% 488
2022
Q1
$337K Hold
1,600
﹤0.01% 484
2021
Q4
$384K Hold
1,600
﹤0.01% 487
2021
Q3
$453K Hold
1,600
﹤0.01% 475
2021
Q2
$554K Sell
1,600
-197,311
-99% -$59.8M ﹤0.01% 465
2021
Q1
$55.6M Sell
198,911
-500
-0.3% -$135K 0.17% 87
2020
Q4
$48.8M Sell
199,411
-4,900
-2% -$1.26M 0.17% 85
2020
Q3
$58M Sell
204,311
-75,060
-27% -$20.9M 0.26% 70
2020
Q2
$74.7M Sell
279,371
-100
-0% -$30.1K 0.35% 63
2020
Q1
$88.4M Buy
279,471
+8,000
+3% +$2.43M 0.5% 53
2019
Q4
$80.6M Buy
271,471
+33,399
+14% +$9.27M 0.28% 74
2019
Q3
$55.4M Buy
238,072
+200
+0.1% +$46.6K 0.22% 85
2019
Q2
$55.6M Sell
237,872
-2,500
-1% -$577K 0.21% 83
2019
Q1
$56.8M Sell
240,372
-4,200
-2% -$1.32M 0.22% 88
2018
Q4
$73.6M Sell
244,572
-8,600
-3% -$2.74M 0.32% 72
2018
Q3
$89.4M Sell
253,172
-9,900
-4% -$3.41M 0.32% 73
2018
Q2
$76.4M Sell
263,072
-4,600
-2% -$1.29M 0.29% 74
2018
Q1
$73.3M Sell
267,672
-4,000
-1% -$1.24M 0.29% 73
2017
Q4
$86.5M Sell
271,672
-3,100
-1% -$994K 0.33% 71
2017
Q3
$86M Sell
274,772
-11,800
-4% -$3.49M 0.34% 70
2017
Q2
$77.8M Hold
286,572
0.31% 71
2017
Q1
$78.4M Sell
286,572
-228
-0.1% -$64.5K 0.31% 72
2016
Q4
$81.3M Sell
286,800
-19,300
-6% -$5.72M 0.33% 74
2016
Q3
$95.8M Buy
306,100
+77,100
+34% +$22.8M 0.4% 64
2016
Q2
$55.4M Buy
+229,000
New +$60.4M 0.24% 90

Other funds holding BIIB